(Q34481601)

2 August 2017

1 reference

title

Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

2 August 2017

0 references

1 reference

Giembycz MA

1

1 reference

PubMed ID

11772257

2 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

1 reference

2 August 2017

10

1 reference

2 August 2017

1361-1379

1 reference

2 August 2017

7

1 reference

A national estimate of the economic costs of asthma

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Mortality by cause for eight regions of the world: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Evaluation of current pharmacotherapy of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Cyclic AMP-dependent regulation of lipid mediators in white cells. A unifying concept for explaining the efficacy of theophylline in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

1,4-Cyclohexanecarboxylates: potent and selective inhibitors of phosophodiesterase 4 for the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Influence of Cigarette Smoking on Drug Metabolism in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

Effects of a selective PDE4 inhibitor, D-22888, on human airways and eosinophils in vitro and late phase allergic pulmonary eosinophilia in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

PDE 4 inhibitors: the use of molecular cloning in the design and development of novel drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.7.1361

10.1517/13543784.10.7.1361

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11772257